CD40L/Mac-1 interaction inhibitors (Freiburg University/Baker IDI Heart and Diabetes Institute)

N/A

Report date: 2025/03/19 11:37:13

Base Information

Drug NameCD40L/Mac-1 interaction inhibitors (Freiburg University/Baker IDI Heart and Diabetes Institute)
Drug Alias NamecM7
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIntegrin beta-2 modulatorsCD40 ligand modulatorsIntegrin alpha-M modulators
TargetsIntegrin beta-2Integrin alpha-MCD40 ligand
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitut Für Mikrosystemtechnik (Imtek), Albert-Ludwigs-Universität Freiburg
China Registration ClassN/A

Develop Information

Active CompaniesInstitut Für Mikrosystemtechnik (Imtek), Albert-Ludwigs-Universität FreiburgBaker Idi Heart And Diabetes Institute Holdings Ltd
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A